Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998; 19: 717-797
Hartmann WH, Sobin LH (eds). Washington, D. C.: Armed Forces Institute of Pathology
Kovacs K, Horvath E. Tumors of the pituitary gland. In: Hartmann WH, Sobin LH (eds). Atlas of Tumor Pathology, Second Series, Fascicle 21. Washington, D. C.: Armed Forces Institute of Pathology, 1986
Cellular localization of the growth hormone receptor/binding protein in the human anterior pituitary gland
Mertani HC et al. Cellular localization of the growth hormone receptor/binding protein in the human anterior pituitary gland. J Clin Endocrinol Metab 1995; 80: 3361-3367
Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture
Oomizu S et al. Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture. J Endocrinol 1998; 157: 53-62
Mortality and cancer incidence in acromegaly: A retrospective cohort study
United Kingdom Acromegaly Study Group
Orme SM et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998; 83: 2730-2734
Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors
Resnicoff M et al. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 1994; 54: 2218-2222
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient
van der Lely AJ et al. Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient. J Clin Endocrinol Metab 2001; 86: 478-481